We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

176 hedge funds and large institutions have $278M invested in Sage Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 58 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more call options, than puts

Call options by funds: $2.74M | Put options by funds: $1.1M

4% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 24

1% more funds holding

Funds holding: 175 → 176 (+1)

0.5% less ownership

Funds ownership: 84.24% → 83.74% (-0.5%)

10% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 58

26% less capital invested

Capital invested by funds: $374M → $278M (-$95.5M)

Holders
176
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
2.32%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
25
Increased
52
Reduced
58
Closed
24
Calls
$2.74M
Puts
$1.1M
Net Calls
+$1.64M
Net Calls Change
-$754K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$23.1M
2
CP
Caligan Partners
New York
+$18.7M
3
BFM
Boothbay Fund Management
New York
+$8.49M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$3.9M
5
Federated Hermes
Federated Hermes
Pennsylvania
+$2.63M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$15.8M
2
State Street
State Street
Massachusetts
-$10.1M
3
PAI
Palo Alto Investors
California
-$7.3M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.06M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$5.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIBC Private Wealth Group
151
CIBC Private Wealth Group
Georgia
$819 – – –
Comerica Bank
152
Comerica Bank
Texas
$652 +$685 +112 +1,400%
BIA
153
Bell Investment Advisors
California
$582 +$544 +89 +494%
SSB
154
Sandy Spring Bank
Maryland
$543 – – –
TFM
155
TFC Financial Management
Massachusetts
$543 – – –
LWCFA
156
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$372 – – –
GI
157
GAMMA Investing
California
$272 -$159 -26 -34%
CA
158
Continuum Advisory
Idaho
$272 – – –
SPIA
159
Steward Partners Investment Advisory
New York
$272 – – –
TC
160
Truvestments Capital
Florida
$212 – – –
TWD
161
True Wealth Design
Ohio
$196 -$960 -157 -81%
FWM
162
FSA Wealth Management
Massachusetts
$190 – – –
FFA
163
Farther Finance Advisors
California
$136 – – –
IA
164
IFP Advisors
Florida
$103 +$116 +19 New
NSIM
165
North Star Investment Management
Illinois
$76 – – –
Jones Financial Companies
166
Jones Financial Companies
Missouri
$65 -$153 -25 -68%
SS
167
SBI Securities
Japan
$54 +$61 +10 New
SC
168
SouthState Corp
Florida
$49 – – –
WWM
169
Wolff Wiese Magana
California
$39 – – –
OP
170
ORG Partners
Indiana
$27 – – –
BTI
171
Blue Trust Inc
Georgia
$11 -$4.04K -661 -100%
AWM
172
Activest Wealth Management
Florida
$5 – – –
FHA
173
First Horizon Advisors
Tennessee
$5 – – –
HNB
174
Huntington National Bank
Ohio
$5 – – –
EWA
175
EverSource Wealth Advisors
Alabama
$5 +$6 +1 New
4 5 6
7
8

SAGE Hedge Fund Activity: Q4 2024 in Review

176 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2024, worth a combined $278M — down 26% from $374M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new SAGE positions and 24 closed out — a net gain of 1 holder — while 52 added to existing stakes and 58 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $23.1M. The largest seller was RTW Investments, cutting an estimated $15.8M.

  • 176 institutional investors held Sage Therapeutics (SAGE) as of Q4 2024, up from 175 in Q3 2024.
  • Funds reported $278M of Sage Therapeutics stock for Q4 2024, down 26% quarter-over-quarter.
  • 25 funds opened new Sage Therapeutics positions in Q4 2024 and 24 closed out, a net change of +1 holder.
  • The largest Sage Therapeutics buyer in Q4 2024 was Morgan Stanley, an estimated $23.1M added.
  • The largest Sage Therapeutics seller in Q4 2024 was RTW Investments, an estimated $15.8M sold.

Based on aggregated 13F filings for Q4 2024.